{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T03:38:24Z","timestamp":1792813104487,"version":"4.5.0"},"reference-count":49,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,6,26]],"date-time":"2025-06-26T00:00:00Z","timestamp":1750896000000},"content-version":"vor","delay-in-days":237,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Revista de Investigaci\u00f3n Cl\u00ednica"],"published-print":{"date-parts":[[2024,11]]},"DOI":"10.24875\/ric.24000176","type":"journal-article","created":{"date-parts":[[2024,12,19]],"date-time":"2024-12-19T18:02:47Z","timestamp":1734631367000},"page":"274-285","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Cardiovascular Risk Prediction Models in People Living with Human Immunodeficiency Virus under Antiretroviral Therapy in Northern Mexico"],"prefix":"10.1016","volume":"76","author":[{"given":"Argui\u00f1e I.","family":"Urraza-Robledo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francisco C.","family":"L\u00f3pez-M\u00e1rquez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Faviel F.","family":"Gonz\u00e1lez-Galarza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Domingo","family":"Pere-Pedrol","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda E.","family":"Guti\u00e9rrez-P\u00e9rez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana P. Roiz-Bollain y","family":"Goytia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pablo","family":"Ruiz-Flores","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fanny K.","family":"Segura-L\u00f3pez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alberto A.","family":"Miranda-P\u00e9rez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.24875\/RIC.24000176_bib1","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1097\/QAD.0b013e3283324283","article-title":"The effect of combined antiretroviral therapy on the overall mortality of HIV-infected individuals","volume":"24","author":"Ray","year":"2010","journal-title":"AIDS (London, England)"},{"issue":"2","key":"10.24875\/RIC.24000176_bib2","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1177\/2047487315579291","article-title":"An updated prediction model of the global risk of cardiovascular disease in HIV-positive persons: The Data-collection on Adverse Effects of Anti-HIV Drugs (D:A:D) study","volume":"23","author":"Friis-M\u00f8ller","year":"2016","journal-title":"Eur J Prev Cardiol"},{"issue":"11","key":"10.24875\/RIC.24000176_bib3","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0048839","article-title":"Long-term survival in HIV positive patients with up to 15 Years of antiretroviral therapy","volume":"7","author":"McManus","year":"2012","journal-title":"PloS one"},{"key":"10.24875\/RIC.24000176_bib4","doi-asserted-by":"crossref","unstructured":"Yanqiao L, Shen L, Yutong M, Linghong S, Ben H. Comparison of GRACE and TIMI risk scores in the prediction of in-hospital and long-term outcomes among East Asian non-ST-elevation myocardial infarction patients. BMC cardiovascular disorders. 2022\/01\/09ed2022. p. 4.","DOI":"10.1186\/s12872-021-02311-z"},{"issue":"3","key":"10.24875\/RIC.24000176_bib5","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1086\/649897","article-title":"Risk of myocardial infarction in patients with HIV infection exposed to specific individual antiretroviral drugs from the 3 major drug classes: the data collection on adverse events of anti-HIV drugs (D:A:D) study","volume":"201","author":"Worm","year":"2010","journal-title":"The Journal of infectious diseases"},{"issue":"4","key":"10.24875\/RIC.24000176_bib6","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1111\/j.1468-1293.2006.00362.x","article-title":"The use of the Framingham equation to predict myocardial infarctions in HIV-infected patients: comparison with observed events in the D:A:D Study","volume":"7","author":"Law","year":"2006","journal-title":"HIV medicine"},{"issue":"8","key":"10.24875\/RIC.24000176_bib7","first-page":"614","volume":"173","author":"Freiberg","year":"2013","journal-title":"HIV infection and the risk of acute myocardial infarction"},{"issue":"2","key":"10.24875\/RIC.24000176_bib8","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1097\/QAI.0000000000000009","article-title":"Immunodeficiency and risk of myocardial infarction among HIV-positive individuals with access to care","volume":"65","author":"Silverberg","year":"2014","journal-title":"Journal of acquired immune deficiency syndromes (1999)"},{"issue":"13","key":"10.24875\/RIC.24000176_bib9","doi-asserted-by":"crossref","first-page":"1911","DOI":"10.1097\/QAD.0000000000000352","article-title":"HIV infection and incidence of ischemic stroke","volume":"28","author":"Marcus","year":"2014","journal-title":"AIDS (London, England)"},{"issue":"7","key":"10.24875\/RIC.24000176_bib10","doi-asserted-by":"crossref","first-page":"2506","DOI":"10.1210\/jc.2006-2190","article-title":"Increased acute myocardial infarction rates and cardiovascular risk factors among patients with human immunodeficiency virus disease","volume":"92","author":"Triant","year":"2007","journal-title":"The Journal of Clinical Endocrinology & Metabolism"},{"issue":"1","key":"10.24875\/RIC.24000176_bib11","first-page":"23","article-title":"Cardiovascular Risk Prediction Models in People Living with HIV in Colombia","volume":"74","author":"Garc\u00eda-Pe\u00f1a","year":"2022","journal-title":"Revista de investigacion clinica; organo del Hospital de Enfermedades de la Nutricion"},{"key":"10.24875\/RIC.24000176_bib12","doi-asserted-by":"crossref","unstructured":"Adela R, Banerjee SKJJodr. GDF-15 as a target and biomarker for diabetes and cardiovascular diseases: a translational prospective. 2015;2015.","DOI":"10.1155\/2015\/490842"},{"issue":"8","key":"10.24875\/RIC.24000176_bib13","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1001\/jamainternmed.2013.3728","article-title":"HIV infection and the risk of acute myocardial infarction","volume":"173","author":"Freiberg","year":"2013","journal-title":"JAMA Intern Med"},{"issue":"3","key":"10.24875\/RIC.24000176_bib14","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1007\/s11904-013-0168-6","article-title":"Cardiovascular disease and HIV infection","volume":"10","author":"Triant","year":"2013","journal-title":"Current HIV\/AIDS reports"},{"issue":"15","key":"10.24875\/RIC.24000176_bib15","doi-asserted-by":"crossref","first-page":"1971","DOI":"10.2165\/00003495-200666150-00006","article-title":"Cardiovascular risk in patients with HIV Infection: impact of antiretroviral therapy","volume":"66","author":"Bergersen","year":"2006","journal-title":"Drugs"},{"issue":"11","key":"10.24875\/RIC.24000176_bib16","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1093\/cid\/cir626","article-title":"Morbidity and Aging in HIV-Infected Persons: The Swiss HIV Cohort Study","volume":"53","author":"Hasse","year":"2011","journal-title":"Clinical Infectious Diseases"},{"issue":"1","key":"10.24875\/RIC.24000176_bib17","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1093\/ckj\/sfaa188","article-title":"External validation of prognostic models: what, why, how, when and where?","volume":"14","author":"Ramspek","year":"2021","journal-title":"Clinical kidney journal"},{"issue":"1","key":"10.24875\/RIC.24000176_bib18","first-page":"11","volume":"8","author":"D'Agostino","year":"2013","journal-title":"Cardiovascular disease risk assessment: insights from Framingham"},{"issue":"2","key":"10.24875\/RIC.24000176_bib19","first-page":"203","volume":"54","author":"Grant","year":"2018","journal-title":"Statistical Primer: developing and validating a risk prediction model"},{"issue":"4","key":"10.24875\/RIC.24000176_bib20","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1007\/s11904-021-00567-w","article-title":"Assessing Cardiovascular Risk in People Living with HIV: Current Tools and Limitations","volume":"18","author":"Achhra","year":"2021","journal-title":"Current HIV\/AIDS reports"},{"key":"10.24875\/RIC.24000176_bib21","doi-asserted-by":"crossref","first-page":"19","DOI":"10.17843\/rpmesp.2017.341.2763","article-title":"Concordancia diagn\u00f3stica entre siete definiciones de s\u00edndrome metab\u00f3lico en adultos con sobrepeso y obesidad","volume":"34","author":"Cabrera-Rode","year":"2017","journal-title":"Revista Peruana de Medicina Experimental y Salud Publica"},{"issue":"2","key":"10.24875\/RIC.24000176_bib22","doi-asserted-by":"crossref","first-page":"362","DOI":"10.2337\/diacare.24.2.362","article-title":"Homeostasis Model Assessment Is a Reliable Indicator of Insulin Resistance During Follow-up of Patients With Type 2 Diabetes","volume":"24","author":"Katsuki","year":"2001","journal-title":"Diabetes Care"},{"issue":"5","key":"10.24875\/RIC.24000176_bib23","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1097\/HJR.0b013e328336a150","article-title":"Predicting the risk of cardiovascular disease in HIV-infected patients: the data collection on adverse effects of anti-HIV drugs study","volume":"17","author":"Friis-M\u00f8ller","year":"2010","journal-title":"European journal of cardiovascular prevention and rehabilitation : official journal of the European Society of Cardiology, Working Groups on Epidemiology & Prevention and Cardiac Rehabilitation and Exercise Physiology"},{"key":"10.24875\/RIC.24000176_bib24","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/s40794-017-0055-z","article-title":"Assessment of the agreement between the Framingham and DAD risk equations for estimating cardiovascular risk in adult Africans living with HIV infection: a cross-sectional study","volume":"3","author":"Noumegni","year":"2017","journal-title":"Tropical diseases, travel medicine and vaccines"},{"issue":"48","key":"10.24875\/RIC.24000176_bib25","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000002201","article-title":"Prevalence of Dyslipidemia Among Antiretroviral-Naive HIV-Infected Individuals in China","volume":"94","author":"Shen","year":"2015","journal-title":"Medicine (Baltimore)"},{"issue":"11","key":"10.24875\/RIC.24000176_bib26","doi-asserted-by":"crossref","first-page":"3390","DOI":"10.1111\/dom.15238","article-title":"Prevalence of obesity and associated complications in China: A cross-sectional, real-world study in 15.8 million adults","volume":"25","author":"Chen","year":"2023","journal-title":"Diabetes, obesity & metabolism"},{"issue":"4","key":"10.24875\/RIC.24000176_bib27","first-page":"1137","article-title":"Impact of obesity on antiretroviral pharmacokinetics and immuno-virological response in HIV-infected patients: a case\u2013control study","volume":"72","author":"Madelain","year":"2017","journal-title":"Journal of Antimicrobial Chemotherapy"},{"key":"10.24875\/RIC.24000176_bib28","doi-asserted-by":"crossref","DOI":"10.1177\/2048004017740478","article-title":"Atherogenic index of plasma and 10-year risk of cardiovascular disease in adult Africans living with HIV infection: A cross-sectional study from Yaound\u00e9, Cameroon","volume":"6","author":"Noumegni","year":"2017","journal-title":"JRSM cardiovascular disease"},{"issue":"7","key":"10.24875\/RIC.24000176_bib29","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1089\/dna.2021.1052","article-title":"Role of \u03b2-Klotho and Malondialdehyde in Metabolic Disorders, HIV Infection, and Antiretroviral Therapy","volume":"41","author":"Guti\u00e9rrez-P\u00e9rez","year":"2022","journal-title":"DNA and cell biology"},{"key":"10.24875\/RIC.24000176_bib30","doi-asserted-by":"crossref","first-page":"49","DOI":"10.2174\/1874192401105010049","article-title":"HIV and HAART-Associated Dyslipidemia","volume":"5","author":"Feeney","year":"2011","journal-title":"The open cardiovascular medicine journal"},{"issue":"4","key":"10.24875\/RIC.24000176_bib31","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1590\/S0036-46652008000400007","article-title":"Alterations in lipid transfer to high-density lipoprotein (HDL) and activity of paraoxonase-1 in HIV+ patients","volume":"50","author":"Daminelli","year":"2008","journal-title":"Revista do Instituto de Medicina Tropical de Sao Paulo"},{"key":"10.24875\/RIC.24000176_bib32","volume":"9","author":"Mar\u00edn-Palma","year":"2018","journal-title":"Lower high-density lipoproteins levels during human immunodeficiency virus type 1 infection are associated with increased inflammatory markers and disease progression"},{"issue":"10","key":"10.24875\/RIC.24000176_bib33","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1097\/QAD.0000000000001109","article-title":"Inflammation, immune activation, and cardiovascular disease in HIV","volume":"30","author":"Nou","year":"2016","journal-title":"AIDS (London, England)"},{"issue":"1 Pt 2","key":"10.24875\/RIC.24000176_bib34","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/0002-8703(91)90861-B","article-title":"Cardiovascular disease risk profiles","volume":"121","author":"Anderson","year":"1991","journal-title":"American heart journal"},{"key":"10.24875\/RIC.24000176_bib35","doi-asserted-by":"crossref","first-page":"51","DOI":"10.2174\/1874613601509010051","article-title":"Risk factors of cardiovascular diseases in HIV\/AIDS patients on HAART","volume":"9","author":"Nsagha","year":"2015","journal-title":"The open AIDS journal"},{"issue":"12","key":"10.24875\/RIC.24000176_bib36","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.1086\/523577","article-title":"Do patterns of comorbidity vary by HIV status, age, and HIV severity?","volume":"45","author":"Goulet","year":"2007","journal-title":"Clinical Infectious Diseases"},{"issue":"4","key":"10.24875\/RIC.24000176_bib37","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1080\/17571472.2014.11493422","article-title":"The prevalence of comorbidities among people living with HIV in Brent: a diverse London Borough","volume":"6","author":"Lorenc","year":"2014","journal-title":"London journal of primary care"},{"issue":"1","key":"10.24875\/RIC.24000176_bib38","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1186\/s12981-023-00572-6","article-title":"Current ART, determinants for virologic failure and implications for HIV drug resistance: an umbrella review","volume":"20","author":"SeyedAlinaghi","year":"2023","journal-title":"AIDS research and therapy"},{"issue":"01","key":"10.24875\/RIC.24000176_bib39","doi-asserted-by":"crossref","first-page":"89","DOI":"10.3855\/jidc.11326","article-title":"Evaluation of cardiovascular risk factors in people living with HIV in S\u00e3o Paulo, Brazil","volume":"14","author":"Melo","year":"2020","journal-title":"The Journal of Infection in Developing Countries"},{"key":"10.24875\/RIC.24000176_bib40","doi-asserted-by":"crossref","DOI":"10.1155\/2023\/1566001","article-title":"Metabolic Syndrome and Combination Antiretroviral Therapy in HIV Patients in Periurban Hospital in Ghana: A Case-Control Study","volume":"2023","author":"Dzudzor","year":"2023","journal-title":"AIDS research and treatment"},{"key":"10.24875\/RIC.24000176_bib41","first-page":"1","article-title":"Metabolic Syndrome Among People Living with HIV Receiving Medical Care in Southern United States: Prevalence and Risk Factors","author":"Sears","year":"2019","journal-title":"AIDS and Behavior"},{"issue":"3","key":"10.24875\/RIC.24000176_bib42","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1080\/15284336.2017.1311502","article-title":"Prevalence of metabolic syndrome in HIV-infected patients naive to antiretroviral therapy or receiving a first-line treatment","volume":"18","author":"Calza","year":"2017","journal-title":"HIV Clinical Trials"},{"issue":"3","key":"10.24875\/RIC.24000176_bib43","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0150970","article-title":"A meta-analysis of the metabolic syndrome prevalence in the global HIV-infected population","volume":"11","author":"Nguyen","year":"2016","journal-title":"PloS one"},{"key":"10.24875\/RIC.24000176_bib44","doi-asserted-by":"crossref","first-page":"126","DOI":"10.2174\/1874613601812010126","article-title":"Metabolic and Cardiovascular Comorbidities Among Clinically Stable HIV Patients on Long-Term ARV Therapy in Five Ambulatory Clinics in Lima-Callao, Peru","volume":"12","author":"Hidalgo","year":"2018","journal-title":"Open AIDS J"},{"issue":"3","key":"10.24875\/RIC.24000176_bib45","doi-asserted-by":"crossref","first-page":"474","DOI":"10.2337\/dc08-1394","article-title":"Presence of the metabolic syndrome is not a better predictor of cardiovascular disease than the sum of its components in HIV-infected individuals: data collection on adverse events of anti-HIV drugs (D:A:D) study","volume":"32","author":"Worm","year":"2009","journal-title":"Diabetes Care"},{"issue":"2","key":"10.24875\/RIC.24000176_bib46","doi-asserted-by":"crossref","first-page":"152","DOI":"10.4103\/ijstd.IJSTD_55_16","article-title":"Assessment of metabolic syndrome in HIV-infected individuals","volume":"38","author":"Theengh","year":"2017","journal-title":"Indian journal of sexually transmitted diseases and AIDS"},{"issue":"5","key":"10.24875\/RIC.24000176_bib47","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1097\/QAI.0000000000002069","article-title":"Predictive Performance of Cardiovascular Disease Risk Prediction Algorithms in People Living With HIV","volume":"81","author":"van Zoest","year":"2019","journal-title":"JAIDS Journal of Acquired Immune Deficiency Syndromes"},{"issue":"1","key":"10.24875\/RIC.24000176_bib48","first-page":"68","article-title":"Subclinical Carotid Atherosclerosis and Reduced DAD Score for Cardiovascular Risk Stratification in HIV-Positive Patients","volume":"114","author":"Silva","year":"2020","journal-title":"Arquivos Brasileiros de Cardiologia"},{"issue":"4","key":"10.24875\/RIC.24000176_bib49","first-page":"e279","volume":"7","author":"So-Armah","year":"2020","journal-title":"HIV and cardiovascular disease"}],"container-title":["Revista de Investigaci\u00f3n Cl\u00ednica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0034837625001925?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0034837625001925?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.clinicalandtranslationalinvestigation.com\/frame_esp.php?id=518","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,2]],"date-time":"2025-07-02T06:11:13Z","timestamp":1751436673000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0034837625001925"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11]]},"references-count":49,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2024,11]]}},"alternative-id":["S0034837625001925"],"URL":"https:\/\/doi.org\/10.24875\/ric.24000176","relation":{},"ISSN":["0034-8376"],"issn-type":[{"value":"0034-8376","type":"print"}],"subject":[],"published":{"date-parts":[[2024,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cardiovascular Risk Prediction Models in People Living with Human Immunodeficiency Virus under Antiretroviral Therapy in Northern Mexico","name":"articletitle","label":"Article Title"},{"value":"Revista de Investigaci\u00f3n Cl\u00ednica","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.24875\/RIC.24000176","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2024 Revista de Investigaci\u00f3n Cl\u00ednica. Published by Permanyer. Published by Elsevier Espa\u00f1a, S.L.U.","name":"copyright","label":"Copyright"}]}}